Law360, New York (March 29, 2010, 1:53 PM ET) -- A federal appeals court has declined to overturn a lower court's decision not to throw out a patent infringement suit brought by Bayer HealthCare LLC against Norbrook Laboratories Ltd. over its efforts to market a generic version of a bovine respiratory disease treatment.
The U.S. Court of Appeals for the Federal Circuit on March 23 declined to hear Norbrook’s interlocutory appeal. A district court judge rejected Norbrook’s motion for judgment on the pleadings in September, prompting the company to appeal the U.S. District Court for the...
Fed. Circ. Refuses To Nix Bayer's Animal Drug IP Suit
To view the full article, take a free trial now.
